Gut microbiota disorder-mediated sphingomyelin was associated with the aggravating effects of low doses of aflatoxin B1 on metabolic dysfunction-associated steatotic liver disease
Research Digest organizes records from OpenAlex API and arXiv API and Crossref REST API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Gut microbiota disorder-mediated sphingomyelin was associated with the aggravating effects of low doses of aflatoxin B1 on metabolic dysfunction-associated steatotic liver disease